Repare Therapeutics, Valence Discovery Partner on AI-Enabled Synthetic Lethality Drug …

For its part of the partnership, Montreal-based Valence will bring its artificial intelligence drug selection platform, which uses a "few-shot learning" …

Link to Full Article: Read Here